Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial Article (Web of Science)

Open Access Industry Collaboration International Collaboration

cited authors

  • Keilholz, Ulrich; Mehnert, Janice M.; Bauer, Sebastian; Bourgeois, Hugues; Patel, Manish R.; Gravenor, Donald; Nemunaitis, John J.; Taylor, Matthew H.; Wyrwicz, Lucjan; Lee, Keun-Wook; Kasturi, Vijay; Chin, Kevin; von Heydebreck, Anja; Gulley, James L.

publication date

  • January 16, 2019


published in

author keyword

  • Avelumab
  • Cutaneous melanoma
  • Immune checkpoint inhibitor
  • Ocular melanoma
  • PD-L1



  • 7